Gastric inhibitory polypeptide links overnutrition to obesity

Ballinger, A.
March 2003
Gut;Mar2003, Vol. 52 Issue 3, p319
Academic Journal
Describes a novel pathway of obesity promotion via gastric inhibitory polypeptide (GIP) and extreme visceral and subcutaneous fat deposition with insulin resistance. High-fat diet fed to mice lacking the GIP receptor; Resistance to obesity of GIP receptor knockout mice.


Related Articles

  • Lack of insulin inhibition on insulin secretion in non-diabetic morbidly obese patients. Muscelli, E; Pereira, J A; Lazarin, M A C T; da Silva, C A; Pareja, J C; Saad, M J A // International Journal of Obesity & Related Metabolic Disorders;Jun2001, Vol. 25 Issue 6, p798 

    OBJECTIVE: Insulin inhibition of insulin secretion has been described in normal lean subjects. In this study, we examined whether this phenomenon also occurs in the morbidly obese who often have severe peripheral insulin resistance. SUBJECTS: Twelve obese patients, normotolerant to glucose (8F/4...

  • Adropin Deficiency Is Associated With Increased Adiposity and Insulin Resistance. Ganesh Kumar, K.; Zhang, Jingying; Gao, Su; Rossi, Jari; McGuinness, Owen P.; Halem, Heather H.; Culler, Michael D.; Mynatt, Randall L.; Butler, Andrew A. // Obesity (19307381);Jul2012, Vol. 20 Issue 7, p1394 

    Adropin is a secreted peptide that improves hepatic steatosis and glucose homeostasis when administered to diet-induced obese mice. It is not clear if adropin is a peptide hormone regulated by signals of metabolic state. Moreover, the significance of a decline in adropin expression with obesity...

  • Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity. Miyashita, Kazutoshi; Itoh, Hiroshi; Tsujimoto, Hirokazu; Tamura, Naohisa; Fukunaga, Yasutomo; Sone, Masakatsu; Yamahara, Kenichi; Taura, Daisuke; Inuzuka, Megumi; Sonoyama, Takuhiro; Nakao, Kazuwa // Diabetes;Dec2009, Vol. 58 Issue 12, p2880 

    OBJECTIVE--Natriuretic peptides (NPs) have been characterized as vascular hormones that regulate vascular tone via guanylyl cyclase (GC), cyclic GMP (cGMP), and cGMP-dependent protein kinase (cGK). Recent clinical studies have shown that plasma NP levels were lower in subjects with the metabolic...

  • Reversal of Obesity and Insulin Resistance by a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice. Min He; Haoran Su; Weiwei Gao; Johansson, Stina M.; Qing Liu; Xiaoyan Wu; Jiayu Liao; Young, Andrew A.; Tamas Bartfai; Ming-Wei Wang // PLoS ONE;2010, Vol. 5 Issue 12, p1 

    Background: Glucagon-like peptide-1 (GLP-1) is recognized as an important regulator of glucose homeostasis. Efforts to utilize GLP-1 mimetics in the treatment of diabetes have yielded clinical benefits. A major hurdle for an effective oral therapy has been the difficulty of finding a...

  • Increased insulin and leptin sensitivity in mice lacking acyl coA: diacylglycerol acyltransferase 1. Chen, Hubert C.; Smith, Steven J.; Ladha, Zuleika; Jensen, Dalan R.; Ferreira, Luis D.; Pulawa, Leslie K.; McGuire, James G.; Pitas, Robert E.; Eckel, Robert H.; Farese Jr., Robert V. // Journal of Clinical Investigation;4/15/2002, Vol. 109 Issue 8, p1049 

    Reveals that inhibition of diacylglycerol acyltransferase 1 (DGAT1) may be useful in treating insulin resistance and leptin resistance in human obesity. Information on the tissue lipid analysis; Effects of DGAT1 deficiency on energy and glucose metabolism in Agouti yellow and leptin-deficient mice.

  • Apolipoprotein C3 Deficiency Results in Diet-Induced Obesity and Aggravated Insulin Resistance in Mice. Duivenvoorden, Ilse; Teusink, Bas; Rensen, Patrick C.; Romijn, Johannes A.; Havekes, Louis M.; Vosholl, Peter J. // Diabetes;Mar2005, Vol. 54 Issue 3, p664 

    Our aim was to study whether the absence of apolipoprotein (apo) C3, a strong inhibitor of lipoprotein lipase (LPL), accelerates the development of obesity and consequently insulin resistance. Apoc3-/- mice and wild-type littermates were fed a high-fat (46 energy %) diet for 20 weeks. After 20...

  • Loss of function mutation in toll-like receptor-4 does not offer protection against obesity and insulin resistance induced by a diet high in trans fat in mice. Vijay-Kumar, Matam; Aitken, Jesse D.; Carvalho, Frederic A.; Ziegler, Thomas R.; Gewirtz, Andrew T.; Ganji, Vijay // Journal of Inflammation;2011, Vol. 8 Issue 1, p1 

    Background: Toll-like receptor-4 (TLR4) triggers inflammatory signaling in response to microbial lipoploysaccharide. It has been reported that loss of TLR4 protected against saturated fat-induced inflammation and insulin resistance. It is not known whether loss of TLR4 function offers protection...

  • Methionine-Restricted C57BL/6J Mice Are Resistant to Diet-Induced Obesity and Insulin Resistance but Have Low Bone Density. Ables, Gene P.; Perrone, Carmen E.; Orentreich, David; Orentreich, Norman // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    Dietary methionine restriction (MR) extends lifespan, an effect associated with reduction of body weight gain, and improvement of insulin sensitivity in mice and rats as a result of metabolic adaptations in liver, adipose tissue and skeletal muscle. To test whether MR confers resistance to...

  • Effects of a potent melanocortin agonist on the diabetic/obese phenotype in yellow mice. Zemel, M B; Moore, J W; Moustaid, N; Kim, J H; Nichols, J S; Blanchard, S G; Parks, D J; Harris, C; Lee, F W; Grizzle, M; James, M; Wilkison, W O // International Journal of Obesity & Related Metabolic Disorders;Jul1998, Vol. 22 Issue 7, p678 

    OBJECTIVE: To test the hypothesis that a melanocortin agonist can reverse obesity and insulin resistance in mice overexpressing the agouti protein. EXPERIMENTAL MODEL: Mice overexpressing the agouti protein either by transgene introduction (β-actin promotor) or by mutation (Ay). DESIGN:...


Read the Article


Sign out of this library

Other Topics